These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33353582)

  • 1. A generic fluticasone propionate and salmeterol dry powder inhaler: Evidence of usability, function, and robustness.
    Tashkin DP; Koltun A; Wallace R
    Allergy Asthma Proc; 2021 Jan; 42(1):30-35. PubMed ID: 33353582
    [No Abstract]   [Full Text] [Related]  

  • 2. Usability and Robustness of the Wixela Inhub Dry Powder Inhaler.
    Allan R; Canham K; Wallace R; Singh D; Ward J; Cooper A; Newcomb C
    J Aerosol Med Pulm Drug Deliv; 2021 Apr; 34(2):134-145. PubMed ID: 32865454
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Response and Cost-Savings Associated With Generic Fluticasone Propionate/Salmeterol Multidose, Dry-Powder Inhaler in Asthma Patients Managed in an Ambulatory Care Practice Setting.
    McCarthy P; Iliadis T; Zaiken K
    J Pharm Pract; 2022 Apr; 35(2):274-280. PubMed ID: 33161797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics, safety, and tolerability of single, high-strength doses of fluticasone propionate and fluticasone propionate/salmeterol delivered via a novel multidose dry powder inhaler in adolescents and adults with persistent asthma.
    Nugent C; Yiu G; Song S; Caracta C
    J Asthma; 2018 Aug; 55(8):898-906. PubMed ID: 28933971
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Shepherd T; Kennett M; Cooper A; Parkinson A
    J Aerosol Med Pulm Drug Deliv; 2022 Jun; 35(3):154-165. PubMed ID: 34726509
    [No Abstract]   [Full Text] [Related]  

  • 7. Consistent Dosing Through the Salmeterol-Fluticasone Propionate Easyhaler for the Management of Asthma and Chronic Obstructive Pulmonary Disease: Robustness Analysis Across the Easyhaler Lifetime.
    Turpeinen A; Eriksson P; Happonen A; Husman-Piirainen J; Haikarainen J
    J Aerosol Med Pulm Drug Deliv; 2021 Jun; 34(3):189-196. PubMed ID: 32960127
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluticasone Propionate/Salmeterol MDPI (AirDuo RespiClick
    Paik J; Scott LJ; Pleasants RA
    Clin Drug Investig; 2018 May; 38(5):463-473. PubMed ID: 29582249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind trial evaluating the efficacy and safety of fluticasone propionate and fluticasone propionate/salmeterol delivered via multidose dry powder inhalers in patients with persistent asthma aged 12 years and older.
    Raphael G; Yiu G; Sakov A; Liu S; Caracta C
    J Asthma; 2018 Jun; 55(6):640-650. PubMed ID: 28763243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Pharmacokinetics of Salmeterol and Fluticasone Propionate 50/100 µg Delivered in Combination as a Dry Powder Via a Capsule-Based Inhaler and a Multi-Dose Inhaler.
    Mehta R; Riddell K; Gupta A; Louey MD; Chan RH
    Clin Drug Investig; 2015 May; 35(5):319-26. PubMed ID: 25805608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma.
    Mansfield L; Yiu G; Sakov A; Liu S; Caracta C
    Allergy Asthma Proc; 2017 Jul; 38(4):264-276. PubMed ID: 28540844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the clinical effects of combined salmeterol/fluticasone delivered by dry powder or pressurized metered dose inhaler.
    Hojo M; Shirai T; Hirashima J; Iikura M; Sugiyama H
    Pulm Pharmacol Ther; 2016 Apr; 37():43-8. PubMed ID: 26898348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma.
    Sher LD; Yiu G; Sakov A; Liu S; Caracta CF
    Allergy Asthma Proc; 2017 Sep; 38(5):343-353. PubMed ID: 28639542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-ranging study of salmeterol using a novel fluticasone propionate/salmeterol multidose dry powder inhaler in patients with persistent asthma.
    Miller DS; Yiu G; Hellriegel ET; Steinfeld J
    Allergy Asthma Proc; 2016 Jul; 37(4):291-301. PubMed ID: 27216137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of the Efficacy of Once-Daily Fluticasone Furoate/Vilanterole with Twice-Daily Fluticasone Propionate/Salmeterol in Elderly Asthmatics.
    Ishiura Y; Fujimura M; Shiba Y; Ohkura N; Hara J; Abo M; Kasahara K
    Drug Res (Stuttg); 2018 Jan; 68(1):38-44. PubMed ID: 28926855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device.
    Tashkin DP; Ohar JA; Koltun A; Allan R; Ward JK
    Pulm Med; 2021; 2021():8881895. PubMed ID: 33815843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Flow Rate Dependency of Delivered Dose and Fine Particle Dose of Salmeterol/Fluticasone Propionate Easyhaler and Seretide Diskus with Patient Flow Rates Collected in a Randomized Controlled Trial.
    Jõgi R; Lähelmä S; Vahteristo M; Happonen A; Haikarainen J
    J Aerosol Med Pulm Drug Deliv; 2019 Apr; 32(2):88-98. PubMed ID: 30300557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler.
    Mehta R; Daley-Yates PT; Jenkins K; Bianco J; Stylianou A; Louey MD; Chan RH
    Pulm Pharmacol Ther; 2014 Oct; 29(1):66-73. PubMed ID: 25035069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.